News

First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump
November 12, 2019
Atherosclerotic Cardiovascular Disease (ASCVD) Patients Face Barriers Reaching Guideline-Recommended Cholesterol Goals
November 8, 2019
…
VIVA19: Round of Late-Breaking Clinical Trial Results Announced: Zilver PTX, SELUTION SFA, RANGER II SFA, IN.PACT Global, B-Laser Atherectomy, IMPERIAL
November 8, 2019
LAS VEGAS, Nov. 8, 2019 — VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the first round of 21 highly anticipated late-breaking clinical…
VIVA19: New Round of Unpublished Clinical Trial Results - TOBA II BTK, ABSORB BTK, PROMISE I, TANGO, ULYSSE
November 8, 2019
LAS VEGAS, November 8, 2019 -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the third round of 21 highly anticipated late-breaking…
VIVA19: Unpublished Late-Breaking Clinical Trial Results Announced: IN.PACT AV Access, Lateral Subdermic Plexus Insufficiency, CLOUT, EXTRACT-PE, DISAPEAR
November 8, 2019
LAS VEGAS, Nov. 6, 2019 /PRNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final round of 21 highly anticipated late-…
Penumbra Indigo Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints
November 7, 2019
…
Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN‑4001, First Multigenic Investigational Therapeutic Candidate for Treatment of Heart Failure
November 7, 2019
…
LimFlow Announces Positive Six-Month Data From Promise I U.S. Early Feasibility Study Demonstrating Excellent Amputation Free Survival and Wound Healing in No-Option Patient Population
November 7, 2019
Results Presented at Vascular Interventional Advances (VIVA) Conference
Boston Scientific Announces Positive Data for the Ranger™ Drug-Coated Balloon and the Eluvia™ Drug-Eluting Vascular Stent at VIVA19
November 6, 2019
Late-breaking clinical trial data demonstrate high rates of primary patency and significantly lower rates of clinically-driven target lesion revascularization for peripheral drug-eluting device por
Saranas Announces First Commercial Case With Early Bird Bleed Monitoring System in the U.S.
November 6, 2019
Novel technology offers physicians first and only real-time detection and monitoring of endovascular bleed complications